CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 380 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 76-100 of 380 matching filings.

Per page
25
Current page
4
424B5 File 333-279285

PROSPECTUS

Filing date
24 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
23 Oct 2024
Reporting date
23 Oct 2024
Next action
Verify source filing
PRE 14A File 001-39126

FORM PRE 14A

Filing date
15 Oct 2024
Reporting date
26 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
12 Sep 2024
Reporting date
10 Sep 2024
Next action
Verify source filing
10-Q File 001-39126

FORM 10-Q FOR JUNE 2024

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
07 Aug 2024
Reporting date
06 Aug 2024
Next action
Verify source filing
4

4

Filing date
06 Aug 2024
Reporting date
30 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
06 Aug 2024
Reporting date
29 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-280790

EFFECT filing

Filing date
02 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-93973

SC 13D

Filing date
02 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-280074

REQUEST FOR WITHDRAWAL

Filing date
31 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-279285

FORM 424B3

Filing date
30 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
30 Jul 2024
Reporting date
30 Jul 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
30 Jul 2024
Reporting date
29 Jul 2024
Next action
Verify source filing
424B5 File 333-279285

PROSPECTUS

Filing date
26 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
26 Jul 2024
Reporting date
26 Jul 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
24 Jul 2024
Reporting date
19 Jul 2024
Next action
Verify source filing
S-1/A File 333-280074

AMENDMENT NO. 1

Filing date
19 Jul 2024
Reporting date
Not listed
Next action
Verify source filing
S-1 File 333-280790

FORM S-1

Filing date
12 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
09 Jul 2024
Reporting date
05 Jul 2024
Next action
Verify source filing
424B5 File 333-279285

FORM 424B5

Filing date
05 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93973

SC 13G filing

Filing date
02 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .